Latest Zealand Pharma News & Updates

See the latest news and media coverage for Zealand Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Zealand Pharma

Biotechnology company focused on metabolic health medicines

zealandpharma.com
Headquarters
Søborg (Copenhagen), Denmark
Founded year
1998
Company type
Public company
Number of employees
200–600

Last updated

Latest news about Zealand Pharma

In short: Zealand Pharma outperformed Q1 2026 revenue expectations, initiated a DKK 1.3 billion share buyback, and advanced key weight-loss drug candidates.

Company announcements

  • Zealand Pharma

    Zealand Pharma reports Q1 2026 financial results

    Announces Phase 3 progression for petrelintide and positive survodutide Phase 3 topline results. Launches a USD 200 million share buy-back and opens a Cambridge research hub.

  • Zealand Pharma

    Zealand Pharma initiates USD 200 million buy-back program

    It authorizes repurchases up to DKK 1.3 billion (7,152,557 shares) from May 7 to October 31, 2026.

  • Zealand Pharma

    Zealand Pharma convenes Extraordinary General Meeting

    The meeting is scheduled for May 26, 2026, at 1:00 pm CEST in Copenhagen. Further details are in accompanying materials.

  • Zealand Pharma

    Zealand Pharma and Roche advance petrelintide to Phase 3 trials

    Trials for chronic weight management start in second half of 2026. Petrelintide showed double-digit weight loss in Phase 2 with good tolerability.

Unlock all announcements with a

Media coverage

  • Reuters

    Zealand unveils buyback, Roche payments; shares rise

    Danish drug ​developer Zealand ‌Pharma reported ​a smaller-than-expected ​first-quarter operating loss ⁠on ​Thursday, boosted ​by strong momentum ​in ​its obesity drug ‌pipeline, ⁠and said it...

  • Børsen

    Zealand surprises with share purchase for 1.3 billion kr.

    Zealand surprises with share purchase for 1.3 billion kr. Zealand Pharma has Thursday morning submitted its report for the first quarter and announces in the same connection that the company...

  • MSN

    Zealand Pharma A/S (ZLDPF) reports Q1 loss, lags revenue estimates

    Zealand Pharma A/S (ZLDPF) came out with a quarterly loss of $0.87 per share versus the Zacks Consensus Estimate of a loss of $1.57. This...

  • Euroinvestor

    Investors punished FLSmidth after news - while Zealand Pharma was sent up: This is how the trading day went

    Investors started the day by sending the shares down, but towards lunchtime the mood shifted, and Danish shares therefore ended in green territory. The C25 index, which counts...

Unlock all articles with a

Never miss news about Zealand Pharma

Track Zealand Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Zealand Pharma competitors & trending companies

Browse news for competitors to Zealand Pharma and other trending companies.